Alignment Healthcare, Inc. (NASDAQ:ALHC)
| Market Cap | 1.71B-54.4% |
| Revenue (ttm) | 4.58B+37.2% |
| Net Income | 40.70M+179.9% |
| EPS | 0.19+168.5% |
| Shares Out | 207.44M |
| PE Ratio | 41.25 |
| Forward PE | 25.96 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,708,721.256 |
| Open | 7.99 |
| Previous Close | 8.05 |
| Day's Range | 7.95 - 8.28 |
| 52-Week Range | 6.01 - 25.12 |
| Beta | 1.14 |
| Analysts | Buy |
| Price Target | 11.83(+43.75%) |
| Earnings Date | Oct 29, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About ALHC
Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
7 firms rating ALHC in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Oct 29, 2026Earnings report
Ask Barron about ALHC
$ALHC stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ALHC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ALHC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ALHC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ALHC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ALHC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ALHC
| ETF | Est. Holding Size |
|---|---|
| IJRiShares Core S&P Small-Cap ETF | $87.79M |
| VTIVanguard Morningstar Total Stock Market ETF | $48.37M |
| IWMiShares Russell 2000 ETF | $40.42M |
| VBVanguard Morningstar Small-Cap ETF | $34.31M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $19.10M |
| VXFVanguard Extended Market ETF | $17.20M |
Estimated from each fund’s disclosed top holdings × AUM
ALHC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ALHC’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score